Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction

Nicholas J Clemons, Wayne A. Phillips, Reginald V. Lord

Research output: Contribution to journalReview ArticleResearchpeer-review

29 Citations (Scopus)


Esophageal adenocarcinoma develops in response to severe gastroesophageal reflux disease through the precursor lesion Barrett esophagus, in which the normal squamous epithelium is replaced by a columnar lining. The incidence of esophageal adenocarcinoma in the United States has increased by over 600% in the past 40 years and the overall survival rate remains less than 20% in the community. This review highlights some of the signaling pathways for which there is some evidence of a role in the development of esophageal adenocarcinoma. An increasingly detailed understanding of the biology of this cancer has emerged recently, revealing that in addition to the well-recognized alterations in single genes such as p53, p16, APC, and telomerase, there are interactions between the components of the reflux fluid, the homeobox gene Cdx2, and the Wnt, Notch, and Hedgehog signaling pathways.

Original languageEnglish
Pages (from-to)782-795
Number of pages14
JournalCancer Biology and Therapy
Issue number9
Publication statusPublished - 2013
Externally publishedYes


  • Adiponectin
  • Barrett esophagus
  • Esophageal adenocarcinoma
  • Leptin
  • Receptor tyrosine kinases
  • Signaling pathways

Cite this